In the validation, RIN1 specifically inhibited PD-L1 expression in HCC cells (Figs. 6a-e, Supplementary Fig. 9a), but had no effect on PD-L2 and MHC-I molecules (Supplementary Fig. 9b, c). Here, RIN1 is linked to hepatocellular carcinoma.